< Back to front page Text size +

Stem cell stars found company to reprogram adult cells

Posted by Elizabeth Cooney  November 29, 2007 06:45 PM
  • Facebook
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.

E-mail this article

Invalid email address
Invalid email address

Sending your article

Your article has been sent.

Some of Boston's heavy hitters in stem cell biology announced today that they have launched a company to commercialize technology that will reprogram mature adult cells into stem cells.

Dr. David Scadden of the Harvard Stem Cell Institute and Massachusetts General Hospital and Dr. Leonard Zon of Harvard University and Children's Hospital Boston are among the founders of Fate Therapeutics. Biomedical engineers Robert Langer and Ram Sasisekharan of MIT will sit on the new biotech's scientific advisory board. The Waltham venture capital company Polaris Venture Partners is a founding investor, with general partner Amir Nashat taking a seat on its board of directors.

The company has a facility in Seattle, and plans to open other offices soon in the Boston area as well as in California.

Fate plans to develop drugs to "awaken" adult stem cells in the body to repair damaged tissues, as well as drugs that turn back the clock in mature cells, bringing them back to the stem cell stage when they have the capacity to grow into other kinds of cells in the body, the company said in a news release. This avoids the use of embryonic stem cells, which is opposed by some because the work entails destruction of early-stage embryos.

The company said its first drug candidate would be cancer-related, but it also expects to target other diseases.

Other principals in the company come from Stanford, the University of Washington and the Scripps Research Institute. Other venture capital investors are ARCH Venture Partners, Venrock and OVP.

  • Facebook
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.

About white coat notes

White Coat Notes covers the latest from the health care industry, hospitals, doctors offices, labs, insurers, and the corridors of government. Chelsea Conaboy previously covered health care for The Philadelphia Inquirer. Write her at cconaboy@boston.com. Follow her on Twitter: @cconaboy.
health answers

Long-term health consequences to being born prematurely? It's estimated that each year nearly 500,000 babies in the United States are born prematurely, or before 37 weeks of pregnancy. Submit question | More answers

Health&Wellness video

Health search

Find news and information on:
archives